Global High Purity Medical Grade Isosorbide Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

According to our (Global Info Research) latest study, the global High Purity Medical Grade Isosorbide market size was valued at US$ 68.51 million in 2025 and is forecast to a readjusted size of US$ 83.01 million by 2032 with a CAGR of 2.8% during review period.
High-purity pharmaceutical-grade isosorbide is a high-purity chemical substance used in the pharmaceutical field. Isosorbide is a diol extracted from plant-derived materials (such as corn starch) and belongs to the cyclic sugar alcohol family. It exhibits good biocompatibility and biodegradability. In the pharmaceutical industry, isosorbide and its derivatives are used to produce drugs for treating cardiovascular diseases, demonstrating good pharmacological activity and safety. Isosorbide is also an effective osmotic oral diuretic. The demand for pharmaceutical-grade isosorbide is estimated at approximately 5,500 tons by 2025.
In recent years, with the continuous upgrading of the global pharmaceutical industry and the deepening of the green chemical concept, high-purity medical-grade isosorbide, as an important bio-based pharmaceutical raw material, has seen a sustained increase in market attention. Isosorbide is derived from renewable biomass resources such as corn and starch, and is prepared through the dehydration of sorbitol. It exhibits good biocompatibility, stability, and low toxicity. In the fields of pharmaceutical intermediates, high-end formulations, and functional pharmaceutical materials, high-purity isosorbide is gradually becoming one of the important functional chemicals.
With the increasing number of cardiovascular disease patients worldwide and the continued growth in demand for related drugs, the demand for high-purity medical-grade isosorbide remains stable. Meanwhile, in high-end formulations, biopharmaceuticals, and specialty drug systems, isosorbide can be used as a stabilizer, functional excipient, and green chemical raw material; its high purity and low impurity characteristics can improve the safety and stability of drugs.
In terms of product structure, high-purity medical-grade isosorbide typically requires a purity of over 99%, with strict control over moisture, heavy metals, and organic impurities to meet international pharmacopoeia standards such as USP, EP, and ChP. From a technological perspective, the industry is moving towards continuous production, high-purity refining, and green processes. Optimizing catalytic systems and separation and purification technologies improves product consistency and production efficiency. Meanwhile, with increasingly stringent global pharmaceutical regulations, quality management systems and GMP production capabilities have become crucial barriers to entry for companies entering the high-end market.
In terms of the industry chain, upstream suppliers include bio-based raw material suppliers such as glucose and sorbitol; midstream producers are high-purity isosorbide manufacturers; and downstream manufacturers are pharmaceutical intermediates and pharmaceutical companies. The industry as a whole has high technological barriers, especially in high-purity control, refining processes, and quality stability, placing high demands on companies' R&D and manufacturing capabilities. As the global pharmaceutical industry increasingly focuses on green raw materials and sustainable supply chains, companies with large-scale and high-standard production capabilities will gain a market advantage.
From a regional market perspective, Europe and North America have stable demand in the high-end pharmaceutical and bio-based chemical sectors, with high requirements for product quality and compliance certifications. The Asia-Pacific region is the fastest-growing region, driven by the rapid development of the pharmaceutical manufacturing industry, with significant market potential in China, India, and Japan. Demand in Latin America and the Middle East is gradually being released against the backdrop of the expansion of the basic pharmaceutical industry. Overall, the global market exhibits a development pattern of "high-end + green" development.
Looking ahead, the global market for high-purity medical isosorbide will be driven by three core factors: first, the continued growth in demand for high-end pharmaceutical intermediates; second, the strengthening trend of green pharmaceutical manufacturing and bio-based materials; and third, the continuous upgrading of high-purity production processes and international quality standards. Market growth is not only reflected in the expansion of demand but also in the increased value brought about by high-value-added pharmaceutical applications.
This report is a detailed and comprehensive analysis for global High Purity Medical Grade Isosorbide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global High Purity Medical Grade Isosorbide market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global High Purity Medical Grade Isosorbide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global High Purity Medical Grade Isosorbide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032
Global High Purity Medical Grade Isosorbide market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for High Purity Medical Grade Isosorbide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global High Purity Medical Grade Isosorbide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roquette, Yu Teng, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
High Purity Medical Grade Isosorbide market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
99.9%
99%
Market segment by Application
Cardiovascular Drugs
Dehydration Diuretics
Others
Major players covered
Roquette
Yu Teng
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe High Purity Medical Grade Isosorbide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of High Purity Medical Grade Isosorbide, with price, sales quantity, revenue, and global market share of High Purity Medical Grade Isosorbide from 2021 to 2026.
Chapter 3, the High Purity Medical Grade Isosorbide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the High Purity Medical Grade Isosorbide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and High Purity Medical Grade Isosorbide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of High Purity Medical Grade Isosorbide.
Chapter 14 and 15, to describe High Purity Medical Grade Isosorbide sales channel, distributors, customers, research findings and conclusion.